Our inaugural Hodgkin Lymphoma conference for Adolescents and Young Adults took place this past Saturday, April 6 at McGill University. A heartfelt thank you to Dr. Nathalie Johnson and our dedicated committee – Nivatha Balendra, Amanda Fiore and Maria Markou. We would like to express our deepest gratitude to our speakers – Dr. Nathalie Johnson, Dr. William Buckett, Isabelle Louis XVI, Thomas Sullivan and Marize Ibrahim. A special thank you as well to our volunteers Eisha Ahmed and Patricio Artusa. Much appreciation to our partners – McGill University, Faculty of Medicine, VOBOC, Allô Mon Coco and FLOW water for generously supporting this event.
Schedule:
1:00 PM – 1:30 PM: Hodgkin Lymphoma 101 (English)
Dr. Nathalie Johnson, MD, PhD
Division of Hematology, Jewish General Hospital
Associate Professor of Medicine, McGill University
1:30 PM – 2:00 PM: Managing side effects of chemo?
Thomas Sullivan, Pharmacist
2:00 PM – 2:30 PM: Health-Break / Networking
Hodgkin Lymphoma 101 (French)
Dr. Nathalie Johnson, MD, PhD
Division of Hematology, Jewish General Hospital
Associate Professor of Medicine, McGill University
2:40 PM – 3:00 PM: Food is medicine
Isabelle Louis XVI, Nutritionist
3:05 PM – 3:25 PM: How to stay in shape?
Marize Ibrahim, Physiotherapist
3:30 PM – 3:50 PM: Fertility treatment options and long-term effects.
Dr. William Buckett, MD ChB, MD, FRCOG
McGill University Health Centre Reproductive Centre
Royal Victoria Hospital in Montreal
3:50 PM – 4:00 PM: Closing Remarks
Nivatha Balendra
Keynote Speaker:
DR. NATHALIE A. JOHNSON MD, PhD
Division of Hematology, Jewish General Hospital
Associate Professor of Medicine, McGill University
Dr. Nathalie Johnson is an Assistant Professor in the Division of Medicine, Hematology and Oncology at McGill University, and has been based at the Jewish General Hospital since July 2010. Dr. Johnson completed her medical studies at the University of Ottawa, and internal medicine and hematology-oncology training at McGill University. She subsequently completed a clinical fellowship in molecular pathology at the British Columbia Cancer Agency in Vancouver, followed by a PhD in pathology and laboratory medicine at the University of British Columbia. She has been awarded a Fonds de la recherche en santé (FRSQ) Chercheurs-boursiers cliniciens award and a Canada Research Chair in Hematology and Oncology in 2011. Dr. Johnson’s research focuses on studying the inherent biological properties of cancer cells that render them more resistant to chemotherapy.
❖ Presentations from our AYA conference are available upon request.
